The Role of CYBB Gene Mutations in Chronic Granulomatous Disease: Exploring Immunogenicity and Immune Deficiencies | [Journal of Pioneering Medical Sciences • 2025]

Author(s):

1. Wasan Abdulateef Majeed: Department of Biology, College of Education for Pure Science, University of Diyala, Iraq

2. Israa Abdulqader Abdulwahab: Ministry of Education, Resafa 1 Directorate of Education, Iraq

3. Shahad Abduljabbar Mohammed: Department of Biology, College of Education for Pure Science, University of Diyala, Iraq

Abstract:

This study aims to characterise the structural impacts of missense mutations in the CYBB gene associated with Chronic Granulomatous Disease (CGD), by comparing them to wild-type CYBB and to assess their effects on protein stability and dynamics and thus on NADPH oxidase function. The goal is to elucidate the pathogenesis of CGD and inform personalised therapeutic strategies. The study used a computational approach combining data from the ClinVar database to identify and characterise CYBB missense variants. It included sequence conservation analysis, using multiple sequence alignments to identify conserved regions of the CYBB protein. DDMut, a deep-learning based stability assessment tool, was used to predict changes in Gibbs Free Energy (??G) upon mutation. Furthermore, molecular dynamics (MD) simulations were performed to investigate the stability and dynamics of CYBB and selected mutants. Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF) data were analyzed to assess structural stability and flexibility, respectively. K-means clustering was used to group simulations. Analysis revealed numerous missense variants with varying pathogenicity classifications. Many variants classified as "likely benign" were predicted to destabilize the CYBB protein, while some "likely pathogenic" variants were predicted to increase stability. Mutations in conserved regions, including those classified as "likely benign," were found to be destabilizing. MD simulations revealed that some variants, despite maintaining overall structural similarity to the wild-type protein, induced substantial local dynamic alterations. Specific mutations within functional domains such as the transmembrane domain (e.g., S142P, R54G, A156D, I15V) and FAD and NAD-binding domains (e.g., P390L, W361R, G359R, E462A, C537F, K438R, Y476C, M465I) were predicted to be destabilizing. Some mutations outside the defined domains (C257R, F262C, I273V) were also found to be destabilizing. There are inconsistencies between ClinVar classifications and computational predictions regarding the impact of CYBB missense mutations on protein stability and dynamics. Many "likely benign" variants may have functional impacts and some "likely pathogenic" variants might not destabilize the protein. The study highlights the importance of using multiple computational approaches, including structural and dynamic analysis, to assess the impact of mutations in the CYBB gene. These findings contribute to a better understanding of the molecular mechanisms of CGD and will help in the development of more accurate diagnostic and therapeutic strategies. Experimental validation of these predictions is needed to further confirm these findings.

Page(s): 200-212

DOI: 10.47310/jpms2025140825

Published: Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 8, Year: 2025

Keywords:

NADPH oxidase , Missense mutations , Protein stability and dynamics , CYBB , Chronic Granulomatous Disease CGD

References:

[1] Mollin M. .2021 ."Clinical, Functional and Genetic Characterization of 16 Patients Suffering from Chronic Granulomatous Disease Variants - Identification of 11 Novel Mutations in CYBB." Clinical & Experimental Immunology. , 203 : 247-266.

[2] Matteo Di,G. Di .2009 ."Molecular Characterization of a Large Cohort of Patients with Chronic Granulomatous Disease. Identification of Novel CYBB Mutations: An Italian Multicenter Study." Molecular Immunology, 46 : 1935-1941.

[3] Rae J. .1998 .". American Journal of Human Genetics, 62 : 1320-1331.

[4] Jirapongsananuruk O. .2002 .. "CYBB Mutation Analysis in XLinked Chronic Granulomatous Disease." Clinical Immunology, 104 : 73-76.

[5] Arnold D.E.,Heimall J.R. .2017 ."A Review of Chronic Granulomatous Disease." Advances in Therapy. , 34 : 2543-2557.

[6] Martel C. .2012 ."Clinical, Functional and Genetic Analysis of Twenty-Four Patients with Chronic Granulomatous Disease - Identification of Eight Novel Mutations in CYBB and NCF2 Genes.". Journal of Clinical Immunology, 32 : 942-958.

[7] Segal A.W. .1983 ."Absence of Cytochrome b-. in Chronic Granulomatous Disease." New England Journal of Medicine, 308 : 245-251.

[8] Azarova I.E. .2020 ."Polymorphisms of the Gene Encoding Cytochrome b-245 Beta Chain of NADPH Oxidase: Relationship with Redox Homeostasis Markers and Risk of Type 2 Diabetes Mellitus.". Russian Journal of Genetics, 56 : 856-862.

[9] Teahan C. .1987 ."The X-Linked Chronic Granulomatous Disease Gene Codes for the β-. Chain of Cytochrome b−245." Nature, 327 : 720-721.

[10] Staudacher O. and H. von,Bernuth O. and H. von .2024 ."Clinical Presentation, Diagnosis and Treatment of Chronic Granulomatous Disease." Frontiers in Pediatrics. , 12 : .

[11] Gérard B. .2001 ."Characterization of 11 Novel Mutations in the X-Linked Chronic Granulomatous Disease (CYBB Gene). " Human Mutation, 18 : 163-163.

[12] Stasia M.J. .2005 ."Characterization of Six Novel Mutations in the CYBB Gene Leading to Different Sub-Types of X-Linked Chronic Granulomatous Disease.". Human Genetics, 116 : 72-82.

[13] Reis B.C.S. .2021 ."Chronic Granulomatous Disease and Myelodysplastic Syndrome in a Patient with a Novel Mutation in CYBB.". Genes, 12 : 1476.

[14] Roos D. .2021 ."Hematologically Important Mutations: The Autosomal Forms of Chronic Granulomatous Disease (Third Update). " Blood Cells, Molecules and Diseases, 92 : 102596.

[15] Gul I. .2023 ."Novel Mutations in CYBB Gene Cause XLinked Chronic Granulomatous Disease in Pakistani Patients.". Italian Journal of Pediatrics, 49 : 95.

[16] Wu E.Y. .2021 ."Expanding the Clinical Phenotype of Chronic Granulomatous Disease: A Female Patient with a De Novo Mutation in CYBB.". Journal of Clinical Immunology, 41 : 224-226.

[17] .2016 ."ClinVar: Public Archive of Interpretations of Clinically Relevant Variants.". Nucleic Acids Research, : .

[18] .2022 .. [18] "InterPro in 2022." Nucleic Acids Research, : .

[19] .2015 ."UniProt: A Hub for Protein Information.". Nucleic Acids Research, : .

[20] Sievers F.,Higgins D.G.,Russell D.G. .2014 ."Clustal Omega, Accurate Alignment of Very Large Numbers of Sequences." Multiple Sequence Alignment Methods. , 10(7) : 6-116.

[21] .2023 ."DDMut: Predicting Effects of Mutations on Protein Stability Using Deep Learning.". Nucleic Acids Research, : .

[22] .2023 .. [22] "OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentials." Journal of Physical Chemistry B, : .

[23] Buratti E. .2007 ."Aberrant 5' Splice Sites in Human Disease Genes: Mutation Pattern, Nucleotide Structure and Comparison of Computational Tools That Predict Their Utilization.". Nucleic Acids Research, 35 : 4250-4263.

[24] Byrum S. .2012 ."Analysis of Stable and Transient ProteinProtein Interactions." Methods in Molecular Biology. , 833 : 143-152.

[25] Yu L. .2023 ."De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease. " Journal of Clinical Immunology, 43 : 88-100.

[26] Sevim-Wunderlich S. .2024 ."A Mouse Model of X-Linked Chronic Granulomatous Disease for the Development of CRISPR/Cas9 Gene Therapy.". Genes, 15 : 706.

[27] Zerbe C.S. .2024 .. and S.M. Holland. "Functional Neutrophil Disorders: Chronic Granulomatous Disease and Beyond." Immunological Reviews, 322 : 71-80.

[28] B.E. . ."Novel Intronic Variant in CYBB Causing X-Linked Chronic Granulomatous Disease. Case Report." Medical Reports, 5(2024) : 100060.

[29] .2006 ."A Novel Missense Mutation in CYBB Gene in Chronic Granulomatous Disease. " Journal of Allergy and Clinical Immunology, 6749(06) : 03489-0.

[30] .2020 ."Variable Presentation of the CYBB Mutation in One Family, Approach to Management and a Review of the Literature.". Case Reports in Medicine, : .

[31] El Kares,R. Kares .2006 ."Genetic and Mutational Heterogeneity of Autosomal Recessive Chronic Granulomatous Disease in Tunisia.". Journal of Human Genetics, 51 : 887-895.

[32] de Albuquerque J.A.T. .2018 ."A C126R de Novo Mutation in CYBB Leads to X-Linked Chronic Granulomatous Disease with Recurrent Pneumonia and BCGitis." Frontiers in Pediatrics. , 6 : .

Citations

Downloads

Views